222 related articles for article (PubMed ID: 18784835)
21. Reconstitution of functional human B lymphocytes in NOD/SCID mice engrafted with ex vivo expanded CD34(+) cord blood cells.
Li C; Ando K; Kametani Y; Oki M; Hagihara M; Shimamura K; Habu S; Kato S; Hotta T
Exp Hematol; 2002 Sep; 30(9):1036-43. PubMed ID: 12225795
[TBL] [Abstract][Full Text] [Related]
22. The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma.
Lyu MA; Pham LV; Sung B; Tamayo AT; Ahn KS; Hittelman WN; Cheung LH; Marks JW; Cho MJ; Ford RJ; Aggarwal BB; Rosenblum MG
Biochem Pharmacol; 2012 Aug; 84(4):451-8. PubMed ID: 22687624
[TBL] [Abstract][Full Text] [Related]
23. Activation of LXR attenuates collagen-induced arthritis via suppressing BLyS production.
Huang Y; Fu X; Lyu X; Xu Z; He Z; Zhang Y; Zeng Y; He F; Huang G
Clin Immunol; 2015 Dec; 161(2):339-47. PubMed ID: 26431776
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.
Cambridge G; Stohl W; Leandro MJ; Migone TS; Hilbert DM; Edwards JC
Arthritis Rheum; 2006 Mar; 54(3):723-32. PubMed ID: 16508933
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.
Yan M; Brady JR; Chan B; Lee WP; Hsu B; Harless S; Cancro M; Grewal IS; Dixit VM
Curr Biol; 2001 Oct; 11(19):1547-52. PubMed ID: 11591325
[TBL] [Abstract][Full Text] [Related]
26. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
27. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival.
Woodland RT; Fox CJ; Schmidt MR; Hammerman PS; Opferman JT; Korsmeyer SJ; Hilbert DM; Thompson CB
Blood; 2008 Jan; 111(2):750-60. PubMed ID: 17942753
[TBL] [Abstract][Full Text] [Related]
28. BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex.
Hase H; Kanno Y; Kojima M; Hasegawa K; Sakurai D; Kojima H; Tsuchiya N; Tokunaga K; Masawa N; Azuma M; Okumura K; Kobata T
Blood; 2004 Mar; 103(6):2257-65. PubMed ID: 14630796
[TBL] [Abstract][Full Text] [Related]
29. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
[TBL] [Abstract][Full Text] [Related]
30. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.
Schiemann B; Gommerman JL; Vora K; Cachero TG; Shulga-Morskaya S; Dobles M; Frew E; Scott ML
Science; 2001 Sep; 293(5537):2111-4. PubMed ID: 11509691
[TBL] [Abstract][Full Text] [Related]
31. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.
Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM
Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172
[TBL] [Abstract][Full Text] [Related]
32. Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin.
Parameswaran R; Yu M; Lyu MA; Lim M; Rosenblum MG; Groffen J; Heisterkamp N
Leukemia; 2012 Aug; 26(8):1786-96. PubMed ID: 22373785
[TBL] [Abstract][Full Text] [Related]
33. A role for BLyS in the activation of innate immune cells.
Chang SK; Arendt BK; Darce JR; Wu X; Jelinek DF
Blood; 2006 Oct; 108(8):2687-94. PubMed ID: 16825497
[TBL] [Abstract][Full Text] [Related]
34. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.
Treml LS; Carlesso G; Hoek KL; Stadanlick JE; Kambayashi T; Bram RJ; Cancro MP; Khan WN
J Immunol; 2007 Jun; 178(12):7531-9. PubMed ID: 17548587
[TBL] [Abstract][Full Text] [Related]
35. Autoantibody production significantly decreased with APRIL/BLyS blockade in murine chronic rejection kidney transplant model.
Bath NM; Ding X; Verhoven BM; Wilson NA; Coons L; Sukhwal A; Zhong W; Redfield Iii RR
PLoS One; 2019; 14(10):e0223889. PubMed ID: 31647850
[TBL] [Abstract][Full Text] [Related]
36. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.
Tournoy KG; Depraetere S; Pauwels RA; Leroux-Roels GG
Clin Exp Immunol; 2000 Jan; 119(1):231-9. PubMed ID: 10606988
[TBL] [Abstract][Full Text] [Related]
37. Space, selection, and surveillance: setting boundaries with BLyS.
Miller JP; Stadanlick JE; Cancro MP
J Immunol; 2006 Jun; 176(11):6405-10. PubMed ID: 16709796
[TBL] [Abstract][Full Text] [Related]
38. Restoration of human B-cell differentiation into NOD-SCID mice engrafted with gene-corrected CD34+ cells isolated from Artemis or RAG1-deficient patients.
Lagresle-Peyrou C; Benjelloun F; Hue C; Andre-Schmutz I; Bonhomme D; Forveille M; Beldjord K; Hacein-Bey-Abina S; De Villartay JP; Charneau P; Durandy A; Fischer A; Cavazzana-Calvo M
Mol Ther; 2008 Feb; 16(2):396-403. PubMed ID: 18223550
[TBL] [Abstract][Full Text] [Related]
39. TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis.
Qin Q; Chang Y; Wang D; Wu Y; Zhang LL; Wei W
Int Immunopharmacol; 2011 Dec; 11(12):2167-75. PubMed ID: 21996540
[TBL] [Abstract][Full Text] [Related]
40. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.
Fu L; Lin-Lee YC; Pham LV; Tamayo A; Yoshimura L; Ford RJ
Blood; 2006 Jun; 107(11):4540-8. PubMed ID: 16497967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
